More Than Hypomyelination in Pol-III Disorder

Abstract The 4H syndrome (hypomyelination, hypodontia, hypogonadotropic hypogonadism) is a newly recognized leukodystrophy. The classical form is characterized by the association of hypomyelination, abnormal dentition, and hypogonadotropic hypogonadism, but the recent identification of 2 genes responsible for the syndrome demonstrates that these 3 main characteristics can be variably combined among “Pol-III (polymerase III)–related leukodystrophies.” The pathophysiology of this group of diseases is still to be elucidated, and there are no neuropathologic descriptions of brain tissue. We report the clinical, neuroradiologic, and neuropathologic findings of a patient affected by 4H syndrome with confirmed POLR3A mutations. We found a marked loss of oligodendrocytes, varying in severity in different brain regions, and accompanied by severe loss of myelin, moderately severe loss of axons, and patchy perivascular regions of betterpreserved white matter. There was relatively mild white matter astrogliosis and microgliosis. A macrophage reaction involving viable normal-appearing oligodendroglia suggests the possibility of an immunologic process in this disorder. Cortical laminar astrogliosis and mineralization of Layers I and II in particular were present. Thus, despite theuniformly hypomyelinating pattern seen on magnetic resonance imaging, neuropathologic examination reveals a complex heterogeneous leukodystrophy with prominent neuroaxonal and glial involvement in this disorder.

[1]  M. Salmona,et al.  Blood-Brain Barrier Alterations in the Cerebral Cortex in Experimental Autoimmune Encephalomyelitis , 2012, Journal of neuropathology and experimental neurology.

[2]  K. Sakamoto,et al.  Diffuse central hypomyelination presenting as 4H syndrome caused by compound heterozygous mutations in POLR3A encoding the catalytic subunit of polymerase III , 2012, Journal of the Neurological Sciences.

[3]  R. Schiffmann,et al.  4H syndrome with late-onset growth hormone deficiency caused by POLR3A mutations. , 2012, Archives of neurology.

[4]  A. Souza,et al.  More often striatal myelinolysis than pontine? A consecutive series of patients with osmotic demyelination syndrome , 2012, Neurological research.

[5]  F. Charron,et al.  The Hedgehog Pathway Promotes Blood-Brain Barrier Integrity and CNS Immune Quiescence , 2011, Science.

[6]  A. Vanderver,et al.  Recessive mutations in POLR3B, encoding the second largest subunit of Pol III, cause a rare hypomyelinating leukodystrophy. , 2011, American journal of human genetics.

[7]  N. Matsumoto,et al.  Mutations in POLR3A and POLR3B encoding RNA Polymerase III subunits cause an autosomal-recessive hypomyelinating leukoencephalopathy. , 2011, American journal of human genetics.

[8]  A. Vanderver,et al.  Mutations of POLR3A encoding a catalytic subunit of RNA polymerase Pol III cause a recessive hypomyelinating leukodystrophy. , 2011, American journal of human genetics.

[9]  E. Chouery,et al.  A whole-genome scan in a large family with leukodystrophy and oligodontia reveals linkage to 10q22 , 2011, Neurogenetics.

[10]  I. Nonaka,et al.  A case with central and peripheral hypomyelination with hypogonadotropic hypogonadism and hypodontia (4H syndrome) plus cataract , 2011, Journal of the Neurological Sciences.

[11]  O. Birk,et al.  Pelizaeus-Merzbacher-like disease caused by AIMP1/p43 homozygous mutation. , 2010, American journal of human genetics.

[12]  Frederik Barkhof,et al.  Magnetic resonance imaging pattern recognition in hypomyelinating disorders. , 2010, Brain : a journal of neurology.

[13]  E. Boltshauser,et al.  Rare dental peculiarities associated with the hypomyelinating leukoencephalopathy 4H syndrome/ADDH. , 2010, Pediatric dentistry.

[14]  E. Obersztyn,et al.  Hypomyelination, hypogonadotropic hypogonadism, hypodontia – First Polish patient , 2010, Brain and Development.

[15]  A. Vanderver,et al.  Tremor–ataxia with central hypomyelination (TACH) leukodystrophy maps to chromosome 10q22.3–10q23.31 , 2010, neurogenetics.

[16]  P. Vermersch,et al.  4H syndrome: a rare cause of leukodystrophy , 2010, Journal of Neurology.

[17]  D. Larizza,et al.  New case of 4H syndrome and a review of the literature. , 2010, Pediatric neurology.

[18]  Zhijian J. Chen,et al.  RNA Polymerase III Detects Cytosolic DNA and Induces Type I Interferons through the RIG-I Pathway , 2009, Cell.

[19]  R. Schiffmann,et al.  Invited Article: An MRI-based approach to the diagnosis of white matter disorders , 2009, Neurology.

[20]  F. M. Valle,et al.  Hipomielinización central, hipogonadismo hipogonadotrófico e hipodontia : una nueva forma de leucodistrofia , 2008 .

[21]  B. Coulombe,et al.  LARP7 is a stable component of the 7SK snRNP while P-TEFb, HEXIM1 and hnRNP A1 are reversibly associated , 2008, Nucleic acids research.

[22]  M. Teichmann,et al.  The expanding RNA polymerase III transcriptome. , 2007, Trends in genetics : TIG.

[23]  J. Gomori,et al.  Deleterious mutation in the mitochondrial arginyl-transfer RNA synthetase gene is associated with pontocerebellar hypoplasia. , 2007, American journal of human genetics.

[24]  Mathieu Blanchette,et al.  Systematic analysis of the protein interaction network for the human transcription machinery reveals the identity of the 7SK capping enzyme. , 2007, Molecular cell.

[25]  I. Harting,et al.  Ataxia, Delayed Dentition and Hypomyelination: A Novel Leukoencephalopathy , 2007, Neuropediatrics.

[26]  R. Schiffmann,et al.  Mitochondrial aspartyl-tRNA synthetase deficiency causes leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation , 2007, Nature Genetics.

[27]  R. Schiffmann,et al.  Peripheral and central hypomyelination with hypogonadotropic hypogonadism and hypodontia , 2006, Neurology.

[28]  T. Terasaki,et al.  Involvement of organic anion transporters in the efflux of uremic toxins across the blood–brain barrier , 2006, Journal of neurochemistry.

[29]  R. Grossman,et al.  Prominent perivenular spaces in multiple sclerosis as a sign of perivascular inflammation in primary demyelination. , 2005, AJNR. American journal of neuroradiology.

[30]  J. Cooper,et al.  Hippocampal Pathology in the Human Neuronal Ceroid‐Lipofuscinoses: Distinct Patterns of Storage Deposition, Neurodegeneration and Glial Activation , 2004, Brain pathology.

[31]  J. Allman,et al.  Neuropathology provides clues to the pathophysiology of Gaucher disease. , 2004, Molecular genetics and metabolism.

[32]  J. Barciszewski,et al.  5 S rRNA: structure and interactions. , 2003, The Biochemical journal.

[33]  A. Mégarbané,et al.  Leukodystrophy associated with oligodontia in a large inbred family: Fortuitous association or new entity? , 2003, American journal of medical genetics. Part A.

[34]  N. Abbott Astrocyte–endothelial interactions and blood–brain barrier permeability , 2002, Journal of anatomy.

[35]  M. Danhof,et al.  Drug transport across the blood-brain barrier , 1992, Pharmaceutisch Weekblad.

[36]  B. Nordlinger,et al.  Respective Roles of Ammonia, Amino Acids, and Medium‐Sized Molecules in the Pathogenesis of Experimentally Induced Acute Hepatic Encephalopathy , 1983, Journal of neurochemistry.

[37]  D. Ribatti,et al.  Morphofunctional aspects of the blood-brain barrier. , 2012, Current drug metabolism.

[38]  M. Vázquez-López,et al.  [Central hypomyelination, hypogonadotrophic hypogonadism and hypodontia: a new leukodystrophy]. , 2008, Revista de neurologia.